Notably, a serine-to-glycine substitution at residue 367 of AZIN1 was also identified by our method, which is reported to be hyper-edited in HCC patients compared to normal samples in previous studies (16). This evidence concerns the gene AZIN1 and hepatocellular carcinoma.